Matinas BioPharma Hldgs Stock (AMEX: MTNB) stock price, news, charts, stock research, profile.
You can purchase shares of Matinas BioPharma Hldgs (AMEX:MTNB) through any online brokerage.
Other companies in Matinas BioPharma Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).
Matinas BioPharma Hldgs has a consensus price target of $3.00.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.64 last updated February 21, 2025 at 7:58 PM EST.
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.